Funders › MA › Zoll Foundation Inc › 2025
Grants paid by Zoll Foundation Inc, tax year 2025
EIN 46-3630772 · Chelmsford, MA · Form 990-PF, Part XV · NTEE H12
In tax year 2025, Zoll Foundation Inc (EIN 46-3630772) reported 23 grants paid totaling $1,297,743. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2025
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2025 | Murdoch Children's Research Institute Melbourne | U | $93,689 | paid | DR. FERGUSON - RESEARCH FOR LOWER GAS FLOWS DURING RESPIRATORY SUPPORT FOR EXTREMELY PRETERM INFANTS | 202640489349100309 |
| 2025 | Governors of the University of Alberta EDMONTON | D | $89,132 | paid | DR. MORIN - RESEARCH FOR IMPROVING CARDIOPULMONARY RESUSCITATION AND SURVIVAL IN CHILDREN FOLLOWING DROWNING | 202640489349100309 |
| 2025 | The General Hospital Corporation Boston, MA | C | $85,276 | paid | DR. MERETO - RESEARCH FOR DELIVERY OF HIGH-DOSE NITRIC OXIDE THROUGH STANDARD EMCO IN A SWINE MODEL TO FIGHT THE WORLDWIDE MULTI-DRUG RESISTANT PATHOGENS EMERGENCY IN CRITICALLY ILL PATIENTS | 202640489349100309 |
| 2025 | Beth Israel Deaconess Medical Center Boston, MA | B | $84,930 | paid | DR. KRAVITZ - FRESH FROZEN PLASMA TREATMENT FOR GLYCOCALYX DEGRADATION IN SEPSIS | 202640489349100309 |
| 2025 | Beth Israel Deaconess Medical Center Boston, MA | B | $84,231 | paid | DR. LEE - MONITORING PULMONARY EDEMA IN MECHANICALLY VENTILATED PATIENTS USING WEARABLE STETHOSCOPES | 202640489349100309 |
| 2025 | Heidelberg University Hospital HEIDELBERG | U | $82,011 | paid | DR. KATZENSCHLAGER - DOUBLE SEQUENTIAL EXTERNAL DEFIBRILLATION IN REFRACTORY VENTRICULAR FIBRILLATION - D.10054715 KATZENSCHLAGER TRIAL, A MULTICENTRIC CLUSTER RANDOMIZED STUDY | 202640489349100309 |
| 2025 | Dartmouth-Hitchcock Clinic Lebanon, NH | B | $77,896 | paid | DR. ERIC ROTHSTEIN - RATE OPTIMIZATION OF THE VEST CPR-T COMPREHENSIVE CARDIAC ARREST RECOVERY SYSTEM UTILIZING A PORCINE VENTRICULAR FIBRILLATION MODEL | 202640489349100309 |
| 2025 | Rosalind Franklin University of Medicine and Science North Chicago, IL | B | $64,872 | paid | DR. RAZI - SELECTIVE TARGETING OF PERIPHERAL A2-ADRENOCEPTORS WITH A-METHYLNOREPINEPHRINE AS A SUPERIOR ALTERNATIVE TO EPINEPHRINE FOR RESUSCITATION FROM CARDIAC ARREST | 202640489349100309 |
| 2025 | The Medical University of Vienna Austria WIEN | U | $60,000 | paid | DR. HILLEBRAND - THE USE OF EXTRACORPOREAL PHOTOPHERESIS AS IMMUNOMODULATORY THERAPY OF SUBCLINICAL ANTIBODY-MEDICATED REJECTION AFTER LUNG TRANSPLANTATION: A PROSPECTIVE RCT | 202640489349100309 |
| 2025 | Murdoch Children's Research Institute Melbourne | U | $56,315 | paid | DR. TURNER - RESEARCH FOR DECODING RHINOVIRUS PNEUMONIA: HOST DEPENDENCIES AND ABERRANT INFLAMMATION IN THE ALVEOLUS | 202640489349100309 |
| 2025 | Rosalind Franklin University of Medicine and Science North Chicago, IL | B | $54,123 | paid | DR. SAEED - OPTIMIZING THE HEMODYNAMIC MANAGEMENT OF SEPTIC SHOCK BY CONTINUOUS MONITORING OF MICROCIRCULATORY PARAMETERS | 202640489349100309 |
| 2025 | Mayo Clinic Rochester, MN | U | $50,000 | paid | DR. WIERUSZEWSKI - RESEARCH INTO EVALUATION OF PLASMA RENIN CONCENTRATIONS IN CARDIAC SURGERY | 202640489349100309 |
| 2025 | Virginia Commonwealth University Richmond, VA | U | $49,927 | paid | DR. UZELAC - RESEARCH INTO DEVELOPMENT AND VALIDATION OF INDOCYANINE GREEN FLUORESCENCE IMAGING AND AL-ASSISTED ANALYSIS FOR ASSESSING MYOCARDIAL VIABILITY IN DCD HEARTS DURING COLD STORAGE PRESERVATION | 202640489349100309 |
| 2025 | Murdoch Children's Research Institute Melbourne | U | $49,911 | paid | DR. POH - THE MULTIORGAN IMPACT OF ASSISTED VENTILATION TO SUPPORT THE PRETERM LUNG | 202640489349100309 |
| 2025 | Feinstein Institutes for Medical Research Manhasset, NY | D | $49,816 | paid | DR. ENDO - A NOVEL MEASURE FOR ASSESSING POST-CARDIAC ARREST SYNDROME SEVERITY BY USING REAL-TIME MEASUREMENTS OF TRANSCUTANEOUS TISSUE CARBON DIOXIDE | 202640489349100309 |
| 2025 | University of Gondar in Ethiopia GONDAR | U | $49,710 | paid | MR. MIHRET - RESEARCH FOR HELPING RESPIRATORY-DISTRESSED NEONATES SURVIVE USING INTEGRATED BUBBLE CONTINUOUS POSITIVE AIRWAY PRESSURE INNOVATIONS WITHIN PRIMARY HEALTH CARE IN ETHIOPIA | 202640489349100309 |
| 2025 | Case Western Reserve University Cleveland, OH | U | $49,700 | paid | DR. RUTLEDGE - RESEARCH INTO TARGETING PROTEOSTASIS TO IMPROVE CARDIAC FUNCTION AFTER ARREST | 202640489349100309 |
| 2025 | Virginia Commonwealth University Richmond, VA | U | $49,650 | paid | DR LIEBRECHT - INVESTIGATING ANTI-INFLAMMATORY MECHANISMS OF A NOVEL PUMP PRIME SOLUTION FOR CPB AND ECMO | 202640489349100309 |
| 2025 | The General Hospital Corporation Boston, MA | C | $47,500 | paid | DR. MIRANDA - PERMISSIVE HYPOTENSION AFTER CARDIAC SURGERY: A PILOT RANDOMIZED CLINICAL TRIAL | 202640489349100309 |
| 2025 | The Medical University of Vienna Austria WIEN | U | $29,961 | paid | DR. LINTSCHINGER - NEW DIGITAL TOOLS FOR PREHOSPITAL RESUSCITATION RESEARCH (REBECCA STUDY) | 202640489349100309 |
| 2025 | The Medical University of Vienna Austria VIENNA | U | $25,217 | paid | DR. BOLOGHEANU - RESEARCH FOR TREATMENT OUTCOMES IN NEW-ONSET ATRIAL FIBRILLATION IN THE SURGICAL ICU: AN EXPLORATORY STUDY USING HIGH-FIDELITY ECG WAVEFORM DATA | 202640489349100309 |
| 2025 | University of the Sunshine Coast Sippy Downs, QUEENSLAND | U | $11,306 | paid | MS. DERMER - MULTIDISCIPLINARY HEALTHCARE PROFESSIONALS' PERCEPTIONS ON THE EFFECTIVENESS OF INNOVATIVE BASIC LIFE SUPPORT EDUCATION SESSIONS | 202640489349100309 |
| 2025 | University of Alabama at Birmingham Birmingham, AL | B | $2,570 | paid | DR. COUTE - THE EFFECT OF GLUCOSE -INSULIN-POTASSIUM ON CARDIA ARREST RESUSCITATION IN A SWINE MODEL OF PROLONGED UNTREATED VENTRICULAR FIBRILLATION | 202640489349100309 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.